
Core Viewpoint - Sanuwave Health, Inc. is set to present at the 45th Annual Canaccord Genuity Growth Conference, highlighting its position as a leading provider of next-generation, FDA-approved wound care products [1][2]. Company Overview - Sanuwave Health focuses on the research, development, and commercialization of patented, non-invasive medical systems aimed at repairing and regenerating skin, musculoskeletal tissue, and vascular structures [3]. - The company offers an end-to-end wound care portfolio that includes regenerative medicine products designed to restore the body's normal healing processes [4]. Conference Details - The group presentation is scheduled for August 13, 2025, from 9:30 to 9:55 a.m. ET, with opportunities for one-on-one meetings with investors available throughout the conference [2].